August 8, 2007

For Immediate Release

New medical technologies in development at medtech startups

FOOTHILL RANCH, CA --- During the month of July 2007, newly identified startup companies with the following technologies in development were added to the Medtech Startups Database:

  • Laparoscopic surgical instrumentation.
  • Drug eluting stents, including for tracheobronchial application for obstruction casued by lung cancer.
  • Neuromodulation and neurostimulation devices.
  • Micro-catheter based multi-modality device for the revascularization of an occluded vessel in the brain.
  • Subdermal cryogenic remodelling of tissues.
  • Orthopaedic medical devices for the spine and trauma markets.
  • Technologies and products in gastrointestinal medicine, including for treatment of gastroesophageal reflux disease (GERD).
  • Spin-out company focused on ischemia and anemia.
  • Radioactive polymers for brachytherapy in oncology.
  • Devices to treat patients with emphysema.
  • Vascular technology (including prosthetic valves) and others.
  • Instrumentation and devices for use in spine surgery.
  • Antimicrobial, antithrombogenic biocompatible coatings.
  • Flexible endoscopy as minimally invasive interventional technology.
  • Surgical instrument positioning system.
  • Microsurgical cutting instruments.
  • Spine implant technologies.
  • Optical biopsy in oncology.
  • Tissue repair using gene therapy, growth factor biology and tissue regeneration for chronic lower extremity ulcers.
  • Devices focusing on cardiovascular, metabolic, inflammatory and fibrotic diseases.
  • Vascular device technologies.
  • Medical device incubator.
  • Developing catheter based solutions to address unmet clinical needs.
  • Therapeutic contact lenses that deliver medications to the eye.

The Medtech Startups Database is an online, searchable database of startup medtech companies. Currently comprised of over 500 medical technology startup companies recently founded in the U.S. and outside the U.S., the Medtech Startup Companies Database is updated each month with 10 or more companies founded typically within the most recent one year period.  See http://mediligence.com/startups-db.htm.

For additional information, contact Patrick Driscoll, at (949) 859-3401 , or patrick {at} mediligence {dot} com.

About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, dedicated Reports on technology markets and the Medtech Startups Database. 


Tags: ,

 


 

About MedMarket DiligenceLinkedIn profile

Patrick Driscoll founded MedMarket Diligence in October 2001.  Mr. Driscoll has over 20 years experience analyzing and writing on medical technology markets, encompassing medical devices, biotech and biopharmaceuticals. He was co-founder of Medtech Insight and prior to that, a principal at Medical Data International, and in these organizations built syndicated reports businesses and directed the companies' custom consulting activities. Mr. Driscoll received a BS from the University of Dallas, and an MBA from the University of New Hampshire's Whittemore School of Business & Economics. Email: patrick[at]mediligence[dot]com.  

 

Dona Watson is the Managing Editor of MedMarkets. Ms. Watson has an extensive editorial background and focus serving the information needs of the medical technology industry.  She has served in editorial, analyst and writer positions for the MedPro Month publication of Medical Data International, as well as Nicholas Communications, and Biomedical Business International.  In addition, Ms. Watson was president of Catalyst Communications, where she was publisher for an industry newsletter devoted to reimbursement of medical products.  Ms. Watson received a BA from Vanguard University.  Email: dona[at]mediligence[dot]com.

Contact us:

MedMarket Diligence, LLC
51 Fairfield
Foothill Ranch, CA 92610
USA
tel:  949.859.3401
toll-free (in the U.S.):  1-866-820-13577
fax: 949.837.4558
email us


© 2001- MedMarket Diligence, LLC.  All rights reserved.